ACS CAN 2024 Nevada Disclosure

Share

Entity 2024 Donation Amount Percentage of Gross Revenue
Abbvie Inc $100,000 0.20%
Amgen, Inc. $400,000 0.80%
Astellas Pharma US, Inc $10,000 0.02%
Astra Zeneca Pharmaceuticals LP $136,900 0.27%
Autolus Therapeutics $5,000 0.01%
BeiGene USA Inc $50,000 0.10%
Bio Nebraska $1,055 0.00%
Biosimilars Forum $10,000 0.02%
Biotechnology Innovation Organization $27,500 0.05%
Blueprint Medicines  $75,000 0.15%
Boehringer Ingelheim USA  $10,000 0.02%
Bristol-Myers Squibb  $525,000 1.05%
CRISPR Therapeutics $6,000 0.01%
Daiichi Sankyo Inc $35,000 0.07%
Eisai Corporation Of North America $25,000 0.05%
Eli Lilly and Company $70,000 0.14%
EMD Serono Inc $50,000 0.10%
Exelixis, Inc. $100,000 0.20%
Genentech Inc $1,254,000 2.51%
Genmab $70,000 0.14%
Gilead Sciences Inc $85,500 0.17%
Glaxosmithkline $44,500 0.09%
Immunogen Inc $25,000 0.05%
Ipsen Biopharmaceuticals Inc $15,000 0.03%
IPSEN Pharmaceuticals $35,000 0.07%
Johnson & Johnson $327,000 0.65%
Massachusetts Biotechnology Council $10,000 0.02%
Merck & Co Inc $315,000 0.63%
Novartis Pharmaceuticals Corporation $665,000 1.33%
Ohio Life Sciences $2,500 0.00%
Organon $40,000 0.08%
Pfizer Inc. $598,700 1.20%
Pharmaceutical Research And Manufacturers Of America (PhRMA) $223,550 0.45%
Regeneron Pharmaceuticals $100,000 0.20%
Relay Therapeutics $5,000 0.01%
Sandoz $10,000 0.02%
Sanofi US LLC $132,000 0.26%
Syndax Pharmaceuticals Inc $10,000 0.02%
Takeda Oncology $65,000 0.13%